• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长效亮丙瑞林与每日服用布舍瑞林在体外受精中的比较。

Comparison between depot leuprorelin and daily buserelin in IVF.

作者信息

Porcu E, Filicori M, Dal Prato L, Fabbri R, Seracchioli R, Colombi C, Flamigni C

机构信息

Reproductive Medicine Unit, University of Bologna, Italy.

出版信息

J Assist Reprod Genet. 1995 Jan;12(1):15-9. doi: 10.1007/BF02214123.

DOI:10.1007/BF02214123
PMID:7580003
Abstract

OBJECTIVES

To compare the effects of depot and daily forms of GnRH analogs in IVF programs.

METHODS

One hundred seventeen patients undergoing IVF, with no severe male factor, were randomized between two treatment groups. Pituitary desensitization was obtained in group 1 (60 patients) with a single IM injection of leuprorelin (3.75 mg), and in group 2 (57 patients) with buserelin (0.3 mg SC twice daily). In a subgroup of 10 patients (5 for the depot form and 5 for the daily form) several GnRH tests were performed to investigate pituitary desensitization.

RESULTS

No differences were found in the time to reach desensitization. Resumption of pituitary activity occurred in 7 days with the daily form and in about 2 months with the depot form. No significant differences were found in the stimulation pattern, oocyte quality, percentage of fertilization. The pregnancy rate per transfer was slightly, but not significantly, better in the depot group (29.4% vs 25.9%). Implantation rate (11.9% vs 12.3%) and the percentage of miscarriages (26.6% vs 28.5%) were similar.

CONCLUSION

Depot and daily forms of GnRH analogs are equally effective in superovulation induction for IVF. Considering improved patient compliance and preference, depot forms are advantageous.

摘要

目的

比较长效和每日使用剂型的促性腺激素释放激素(GnRH)类似物在体外受精(IVF)方案中的效果。

方法

117例接受IVF且无严重男性因素的患者被随机分为两个治疗组。第1组(60例患者)通过单次肌内注射亮丙瑞林(3.75mg)实现垂体脱敏,第2组(57例患者)通过皮下注射布舍瑞林(0.3mg,每日两次)实现垂体脱敏。在10例患者的亚组中(长效剂型5例,每日剂型5例)进行了多项GnRH测试以研究垂体脱敏情况。

结果

在达到脱敏所需时间上未发现差异。每日剂型在7天恢复垂体活性,长效剂型在约2个月恢复垂体活性。在刺激模式、卵母细胞质量、受精率方面未发现显著差异。长效剂型组每次移植的妊娠率略高,但无显著差异(29.4%对25.9%)。着床率(11.9%对12.3%)和流产率(26.6%对28.5%)相似。

结论

长效和每日使用剂型的GnRH类似物在IVF超排卵诱导中同样有效。考虑到患者依从性和偏好的改善,长效剂型更具优势。

相似文献

1
Comparison between depot leuprorelin and daily buserelin in IVF.长效亮丙瑞林与每日服用布舍瑞林在体外受精中的比较。
J Assist Reprod Genet. 1995 Jan;12(1):15-9. doi: 10.1007/BF02214123.
2
Comparison between depot and standard release triptoreline in in vitro fertilization: pituitary sensitivity, luteal function, pregnancy outcome, and perinatal results.长效释放与标准释放曲普瑞林在体外受精中的比较:垂体敏感性、黄体功能、妊娠结局及围产期结果。
Fertil Steril. 1994 Jul;62(1):126-32. doi: 10.1016/s0015-0282(16)56827-7.
3
Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.不同长效促性腺激素释放激素类似物对女性抑制能力的比较。
J Clin Endocrinol Metab. 1993 Jul;77(1):130-3. doi: 10.1210/jcem.77.1.8325935.
4
Superovulation before IVF by recombinant versus urinary human FSH (combined with a long GnRH analog protocol): a comparative study.体外受精前使用重组人促卵泡激素与尿促卵泡素(联合长效促性腺激素释放激素类似物方案)进行超排卵:一项比较研究。
J Assist Reprod Genet. 1995 Jan;12(1):26-31. doi: 10.1007/BF02214125.
5
Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.长效释放剂型与每日给药的促性腺激素释放激素激动剂方案用于辅助生殖周期中垂体脱敏的比较
Cochrane Database Syst Rev. 2002(3):CD002808. doi: 10.1002/14651858.CD002808.
6
Self-control study on reduced-dose depot versus daily administration of gonadotrophin-releasing hormone agonists for pituitary desensitization in in vitro fertilization cycles.体外受精周期中垂体脱敏时,低剂量长效与每日注射促性腺激素释放激素激动剂的自我对照研究。
J Obstet Gynaecol Res. 2014 Jul;40(7):1901-6. doi: 10.1111/jog.12417.
7
A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: a prospective randomized study.一项体外受精程序中三种促性腺激素释放激素类似物的比较:一项前瞻性随机研究。
Hum Reprod. 1999 Feb;14(2):288-93. doi: 10.1093/humrep/14.2.288.
8
Evaluation of two gonadotropin-releasing hormone (GnRH) analogues (leuprolide and buserelin) in short and long protocols for assisted reproduction techniques.两种促性腺激素释放激素(GnRH)类似物(亮丙瑞林和布舍瑞林)在辅助生殖技术短方案和长方案中的评估。
J Assist Reprod Genet. 1994 Feb;11(2):85-91. doi: 10.1007/BF02215993.
9
Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients.枸橼酸氯米芬与人绝经期促性腺激素:针对部分体外受精失败患者的替代刺激方案。
J Assist Reprod Genet. 1995 Jan;12(1):8-12. doi: 10.1007/BF02214121.
10
An improved use of buserelin in ovarian stimulation for in-vitro fertilization.布舍瑞林在体外受精卵巢刺激中的改良应用。
Hum Reprod. 1990 Jul;5(5):573-4. doi: 10.1093/oxfordjournals.humrep.a137146.

引用本文的文献

1
A Scalable Platform for Fabricating Biodegradable Microparticles with Pulsatile Drug Release.用于制造具有脉冲药物释放功能的可生物降解微球的可扩展平台。
Adv Mater. 2023 Jun;35(22):e2300228. doi: 10.1002/adma.202300228. Epub 2023 Mar 30.
2
Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.长效注射与每日给药的促性腺激素释放激素激动剂方案用于辅助生殖周期中垂体降调节的比较
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD002808. doi: 10.1002/14651858.CD002808.pub3.
3
Comparison between a single dose of goserelin (depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: a clinical endocrinological study of the ovarian response.

本文引用的文献

1
Pregnancy during long-term gonadotropin-releasing hormone agonist therapy associated with clinical pseudomenopause.长期促性腺激素释放激素激动剂治疗期间怀孕与临床假绝经相关。
Fertil Steril. 1993 Feb;59(2):446-7. doi: 10.1016/s0015-0282(16)55702-1.
2
Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.不同长效促性腺激素释放激素类似物对女性抑制能力的比较。
J Clin Endocrinol Metab. 1993 Jul;77(1):130-3. doi: 10.1210/jcem.77.1.8325935.
3
Comparison between depot and standard release triptoreline in in vitro fertilization: pituitary sensitivity, luteal function, pregnancy outcome, and perinatal results.
戈舍瑞林(长效剂型)单次给药与醋酸亮丙瑞林每日多次给药在体外受精治疗中垂体抑制作用的比较:卵巢反应的临床内分泌学研究
J Assist Reprod Genet. 2002 Jul;19(7):313-8. doi: 10.1023/a:1016054424966.
长效释放与标准释放曲普瑞林在体外受精中的比较:垂体敏感性、黄体功能、妊娠结局及围产期结果。
Fertil Steril. 1994 Jul;62(1):126-32. doi: 10.1016/s0015-0282(16)56827-7.
4
Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist.促性腺激素释放激素激动剂对人颗粒细胞孕酮分泌的抑制作用。
J Clin Endocrinol Metab. 1982 May;54(5):1078-80. doi: 10.1210/jcem-54-5-1078.
5
Infusion of gonadotropin-releasing hormone agonist during pregnancy: maternal and fetal responses in primates.孕期注射促性腺激素释放激素激动剂:灵长类动物的母体和胎儿反应
Am J Obstet Gynecol. 1987 Mar;156(3):755-60. doi: 10.1016/0002-9378(87)90092-5.
6
The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT.
Hum Reprod. 1988 Jul;3(5):585-90. doi: 10.1093/oxfordjournals.humrep.a136750.
7
Effect of a luteinizing hormone-releasing hormone agonist (Buserelin) on steroidogenesis of cultured human preovulatory granulosa cells.
Fertil Steril. 1988 Oct;50(4):597-602. doi: 10.1016/s0015-0282(16)60190-5.
8
Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG.在体外受精/配子输卵管内移植(IVF/GIFT)程序中,联合使用促性腺激素释放激素(GnRH)类似物和人绝经期促性腺激素(HMG)对失败周期进行管理。
Hum Reprod. 1987 May;2(4):309-14. doi: 10.1093/oxfordjournals.humrep.a136540.
9
GnRH receptors in human granulosa cells: anatomical localization and characterization by autoradiographic study.人颗粒细胞中的促性腺激素释放激素受体:放射自显影研究的解剖定位与特性分析
Endocrinology. 1989 Sep;125(3):1739-41. doi: 10.1210/endo-125-3-1739.
10
Effect of treatment with gonadotropin-releasing hormone analogues on pregnancy outcome in the baboon.促性腺激素释放激素类似物治疗对狒狒妊娠结局的影响。
Fertil Steril. 1989 Nov;52(5):846-53.